Brief: Adial Pharmaceuticals Granted New U.S. Patent On Method To Identify Genetic Markers In Alcohol or Opioid-Related Disorders

Azora Therapeutics

19/02/2025 15:42

Feb 19 (Reuters) - Adial Pharmaceuticals Inc  ADIL.O :
    * ADIAL PHARMACEUTICALS GRANTED NEW U.S. PATENT EXPANDING
COVERAGE
OF ITS GENETIC-BASED APPROACH TO TREATING AND DIAGNOSING ALCOHOL
USE DISORDER AND OTHER DRUG DEPENDENCIES

Source text:  urn:newsml:reuters.com:*:nGNX41V4YB
Further company coverage:  ADIL.O 

 ((Reuters.Briefs@thomsonreuters.com;))